South Africa’s J&J COVID-19 vaccine rollout to resume on Wednesday

In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine. Pavlo Gonchar/SOPA Images/LightRocket/Getty Images
UKRAINE – 2021/02/05: In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine.
Johnson & Johnson (J&J) has asked regulators to authorize their COVID-19 vaccine for emergency use in the U.S. and also will apply to authorize to EU, reportedly by media. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

South will resume its Johnsons &Johnson vaccination programme on Wednesday this is after the rollout was put on hold following cases of rare blood clots that were reported in six recipients in the United States.

The South African Health Products Regulatory Authority has since found no evidence of blood clots, and health authorities say there is a one in a million chance of getting clotting disorders.

Phase one of the vaccination program, aimed at health workers, is expected to end on 16 May.

Those taking part will be required to give consent again.

Authorities have recommended that pregnant and lactating women be excluded